Search Results - "Lopez, Adriana T"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management by Lopez, Adriana T., Geskin, Larisa

    Published in The oncologist (Dayton, Ohio) (01-10-2018)
    “…Immunotherapy has emerged as a highly effective treatment for numerous cancers. Use of checkpoint inhibitors against various molecules including programmed…”
    Get full text
    Journal Article
  3. 3

    Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma by Lopez, Adriana T., Bates, Susan, Geskin, Larisa

    Published in American journal of clinical dermatology (01-12-2018)
    “…Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that are characterized by primary skin involvement. Mycosis fungoides (MF) and Sézary…”
    Get full text
    Journal Article
  4. 4

    A review of bullous pemphigoid associated with PD‐1 and PD‐L1 inhibitors by Lopez, Adriana T., Khanna, Trisha, Antonov, Nina, Audrey‐Bayan, Claire, Geskin, Larisa

    Published in International journal of dermatology (01-06-2018)
    “…Background Dermatologic toxicity represents a substantial portion of all immune‐related adverse events (irAEs) associated with PD‐1/PD‐L1 inhibitors. Bullous…”
    Get full text
    Journal Article
  5. 5
  6. 6

    UV biomarker genes for classification and risk stratification of cutaneous actinic keratoses and squamous cell carcinoma subtypes by Queen, Dawn, Shen, Yao, Trager, Megan H., Lopez, Adriana T., Samie, Faramarz H., Lewin, Jesse M., Niedt, George W., Geskin, Larisa J., Liu, Liang

    Published in The FASEB journal (01-09-2020)
    “…Currently, there is no sensitive molecular test for identifying transformation‐prone actinic keratoses (AKs) and aggressive squamous cell carcinoma (SCC)…”
    Get full text
    Journal Article
  7. 7

    Fall risk assessment and injury prevention in the Mohs surgery clinic: a review of the literature and recommendations for improving patient safety by Lopez, Adriana T, Fisher, Juliya, Samie, Faramarz H

    Published in Dermatology online journal (2019)
    “…Patient falls remain a major cause of adverse events in the medical setting. Many patients receiving Mohs micrographic surgery are at high risk, both for…”
    Get full text
    Journal Article
  8. 8

    The Role of Oncolytic Viruses in the Treatment of Melanoma by Bayan, Claire-Audrey Y., Lopez, Adriana T., Gartrell, Robyn D., Komatsubara, Kimberly M., Bogardus, Margaret, Rao, Nisha, Chen, Cynthia, Hart, Thomas D., Enzler, Thomas, Rizk, Emanuelle M., Pradhan, Jaya Sarin, Marks, Douglas K., Geskin, Larisa J., Saenger, Yvonne M.

    Published in Current oncology reports (01-10-2018)
    “…Purpose of Review Oncolytic virotherapy is a new approach to the treatment of cancer and its success in the treatment of melanoma represents a breakthrough in…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Secondary prevention strategies for nonmelanoma skin cancer by Lopez, Adriana T, Carvajal, Richard D, Geskin, Larisa

    Published in Dermatology Times (01-06-2018)
    “…SECONDARY PREVENTION Ultraviolet (UV) radiation is the most preventable cause of skin cancer.7 Primary prevention efforts have focused on increasing awareness…”
    Get full text
    Trade Publication Article
  13. 13